Insider Title Company Date Price Return Shares Value
Renaud Ronald C Jr President Cerevel Therapeutics Holdings, Inc. (CERE) 2023-08-03 $23.96 87.7% 83,857 $2,008,811
Return Profit / (loss) Cost
Total 87.7% $1,761,399 $2,008,811